PUBLISHER: The Insight Partners | PRODUCT CODE: 1780304
PUBLISHER: The Insight Partners | PRODUCT CODE: 1780304
The collagen market size is valued at US$ 5.50 billion in 2024 and is projected to reach US$ 7.76 billion by 2031; it is estimated to register a CAGR of 5.1% from 2025 to 2031.
Technological advancements in collagen extraction and processing have significantly transformed collagen-based products' efficiency, purity, and application potential. Innovations such as recombinant technology, precision fermentation, and optimized enzymatic hydrolysis have enabled the development of highly bioavailable, customizable, and sustainable collagen solutions tailored to a wide range of industries, including medical, nutraceuticals, and cosmetics. For instance, in July 2024, Evonik VECOLLAN, a next-generation recombinant collagen, was produced through a controlled, animal-free microbial fermentation process. It offers exceptional biocompatibility and batch-to-batch consistency, critical for advanced biomedical applications such as wound healing, tissue regeneration, and 3D bioprinting. VECOLLAN is engineered for diverse forms and cross-linking options, significantly expanding the functional potential of collagen beyond traditional formats. Similarly, CollPlant Biotechnologies has developed plant-based recombinant human collagen (rhCollagen) using genetically engineered tobacco plants. This unique platform allows for scalable, safe, and sustainable collagen production for medical aesthetics, regenerative medicine, and orthobiologics. CollPlant's partnerships with industry leaders to develop 3D bioprinted implants and aesthetic products underscore these advanced collagen forms' commercial and therapeutic viability. The global collagen market is poised for sustained growth driven by these transformative technological developments.
The growing popularity of high-protein and health-conscious diets significantly contributes to the expansion of the collagen market. Consumers increasingly integrate collagen into their daily nutritional regimes to support joint health, muscle recovery, and overall well-being. As protein-rich diets gain momentum, collagen supplements are recognized as a functional protein source, offering additional benefits beyond basic nutrition. This dietary shift has driven major investment and strategic acquisitions in the collagen market. For example, in May 2024, Vector Consumer acquired Dose & Co, a collagen-focused brand, to expand its product offerings and capitalize on consumer demand for holistic nutrition solutions. Similarly, in April 2023, Darling Ingredients acquired Gelnex, a Brazilian gelatin and collagen producer, to secure a larger global collagen supply chain footprint. The demand for protein-enhanced functional foods and beverages is surging, especially among fitness enthusiasts, aging populations, and health-conscious millennials. Collagen powder, bars, and ready-to-drink beverages are increasingly positioned as essential elements of a balanced, protein-rich diet. Moreover, collagen is gaining traction for its digestibility, bioavailability, and amino acid profile, which align well with the goal of muscle maintenance, skin elasticity, and gut health. As consumers continue to prioritize nutrition as a pillar of health and lifestyle, the role of collagen as a versatile, high-performance protein is expected to strengthen further. The rising incorporation of collagen in everyday diets is poised to unlock new product innovation and broaden its applications across the food, beverages, and dietary supplements sectors, shaping a robust future for the collagen market.
Based on the applications, the collagen market is segmented into food and beverages, pharmaceuticals and nutraceuticals, personal care and cosmetics, animal nutrition, healthcare, and others. Pharmaceuticals and nutraceuticals held a large share of the collagen market in 2024. Collagen is used in pharmaceutical drugs and dietary supplements that boost skin, hair, and nail health, improve muscle growth and recovery, and provide joint and bone support. It stimulates cartilage regeneration, reducing joint pain and inflammation, and improving joint function. Collagen is used in supplements formulated to make bones strong and provide relief from joint pain.
Some of the players operating in the collagen market include GELITA AG, Rousselot BV, Titan Biotech Ltd, Tessenderlo Group NV, Ewald-Gelatine GmbH, BioCell Technology LLC, Lapi Gelatine SpA, Weishardt Holding SA, Nippi Collagen NA Inc, Nitta Gelatin India Ltd, and Darling Ingredients Inc, and others. Players operating in the collagen market focus on providing innovative products at affordable prices to fulfill customer demand.
The overall collagen market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers-along with external consultants such as valuation experts, research analysts, and key opinion leaders-specializing in the collagen market.